We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breakthrough Technology Revolutionizes Breast Imaging

By HospiMedica International staff writers
Posted on 08 Mar 2024

Mammography is currently the primary method for detecting breast cancer at an early stage and improving treatment outcomes. More...

Despite its widespread use, mammography has notable limitations, particularly in terms of sensitivity and reliability in cases of dense breast tissue. Dense breast tissue can lead to 10-15% of mammograms yielding inconclusive results, resulting in additional testing. Besides, mammography also raises safety concerns. It is also problematic for women with breast implants, as mammograms can be painful, delay cancer detection due to interference in imaging breast tissue, and deter women from undergoing mammograms due to fear of implant rupture, dislocation, or capsular contracture. Now, a patient-centric breast imaging technology provides highly accurate, 100% safe, and painless breast imaging that can be used to identify cancer early to minimize invasiveness and increase the effectiveness of treatment. It can also be used to eliminate unnecessary intervention (additional imaging and biopsies) for women with benign breast conditions, most notably cysts.

QT Imaging’s (Novato, CA, USA) QTI Breast Acoustic CT System, featuring the trademarked Breast ACT technology, marks an advancement in breast imaging. It eliminates uncomfortable breast compression, radiation exposure, and the need for contrast agents or injections, prioritizing patient comfort and safety. The state-of-the-art system delivers high-quality, high-resolution 3D images. Moreover, it overcomes the limitations of traditional mammography by providing consistent and reproducible image quality for patients with dense breast tissue or implants. This positions the QTI system as a major advancement in healthcare imaging, setting a new standard in breast imaging excellence.

“The QTI Breast Acoustic CT System represents a leap forward in patient-centric breast imaging,” said Nasser Pirshafiey, Chief Product Officer at QTI. “By harnessing the power of our advanced technology and eliminating the discomfort associated with traditional methods, we're redefining the standard of care and empowering patients with a safer, more comfortable imaging experience.”


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Desk Aneroid Sphyg
Diagnostix 750D+
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.